Medinet (2370) · InitiativeAdvanced
Partnerships for Contract Manufacturing of Specified Cell-Processed Products
First written in FY2016-Q3. 1 of 2 entries say "Advanced", first in FY2018-Q1. Latest entry: FY2018-Q1.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
Launch of a Regenerative Medicine CDMO and Contract Cell Manufacturing BusinessA theme 13 companies write about · 1 as a headwind · 20 as a tailwind
The whole theme swung hardest in 2025: 1 of 10 companies on the "Worse" side.
7 other companies' latest entry also says "Advanced".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- FY2018-Q1AdvancedAnnual report
「Accordingly, with Medical Corporation Koshi Kai, the agreement was changed from a comprehensive support services agreement for immune cell therapy to a new contract manufacturing agreement for specified cell-processed products.」
In addition to the existing agreement with AOI International Hospital, we entered into a contract manufacturing agreement for specified cell-processed products with Koshi Kai. - FY2016-Q3First statedAnnual report
「In February 2016, we entered into a contract manufacturing agreement for specified processed cells with AOI International Hospital, operated by Aoi Medical Corporation.」
The Company entered into a contract manufacturing agreement with AOI International Hospital in February 2016.